$41.29
-0.99 (-2.33%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+103.4% upside
Low Target
$51.90
Average Target
$83.97
High Target
$108.57
Current Price
$41.29
Current
$41.29
$41.29
Target
$83.97
$83.97
$51.90
$83.97 avg
$108.57
Scenario Analysis
Bear Case
$51.90
25.7%
Low target
Base Case
$83.97
+103.4%
Avg target
Bull Case
$108.57
+163.0%
High target
Risk/Reward
6.3x
Highly favorable
Price in Context
52-Week High
$43.73
-5.6% from high
52-Week Low
$10.38
+297.7% from low
50-Day SMA
$37.85
+9.1% vs SMA
200-Day SMA
$20.09
+105.5% vs SMA
RSI (14)
53.0
Neutral
Target vs 52W High
$83.97
+92.0% vs high
Next Earnings Report
Aug 11, 2026
3d
until earnings
EPS Est: $-0.58
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |